Cuorips Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 54

Employees

  • Stock Symbol
  • 4894

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $41.40
  • (As of Friday Closing)

Cuorips General Information

Description

Cuorips Inc is engaged in the Research, development, manufacturing, and sales of Cellular and Tissue-based Products and Cell processing products. The company is also engaged in Contract development and manufacturing services and consulting services of Cellular and Tissue-based Products and Cell processing product.

Contact Information

Website
www.cuorips.co.jp
Formerly Known As
Cuore
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Nakanoshima Qross 8th Floor, O-Nexus, 4-3-51 Nakanoshima
  • Kita-ku
  • Osaka, Osaka Prefecture 103-0023
  • Japan
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
TKS
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • Nakanoshima Qross 8th Floor, O-Nexus, 4-3-51 Nakanoshima
  • Kita-ku
  • Osaka, Osaka Prefecture 103-0023
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cuorips Stock Performance

As of 13-Nov-2026, Cuorips’s stock price is $41.40. Its current market cap is $368M with 8.88M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$41.40 $41.44 $22.48 - $80.29 $368M 8.88M 142K -$0.90

Cuorips Financials Summary

As of 30-Jun-2026, Cuorips has a trailing 12-month revenue of $833K.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 196,579 337,908 412,957 155,352
Revenue 833 1,409 1,149 160
EBITDA (6,340) (3,734) (3,875)
Net Income (7,382) (6,785) (4,225) (4,375)
Total Assets 29,714 32,048 38,369 40,864
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cuorips Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cuorips‘s full profile, request access.

Request a free trial

Cuorips Patents

  • 39

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

Cuorips Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7869600-B1 Method for manufacturing cardiac organoids Active 23-May-2025
JP-2026150774-A Myocardial tissue - collagen's self-moving membrane Pending 12-Mar-2025
WO-2026173009-A1 Container orientation changing device Pending 14-Feb-2025
WO-2026058909-A1 Pharmaceutical or cosmetic composition containing culture supernatant of ips cells or differentiated cells derived from ips cells Pending 10-Sep-2024
WO-2026048613-A1 Organoid for treating heart disease and method for producing same Pending 30-Aug-2024
To view Cuorips’s complete patent history, request access »

Cuorips Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cuorips Investments (1)

Cuorips’s most recent deal was a Early Stage VC with MiL for . The deal was made on 14-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MiL 14-Jan-2022 Early Stage VC Food Products
To view Cuorips’s complete investments history, request access »

Cuorips ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Cuorips’s complete esg history, request access »

Cuorips FAQs

  • When was Cuorips founded?

    Cuorips was founded in 2017.

  • Where is Cuorips headquartered?

    Cuorips is headquartered in Osaka, Japan.

  • What is the size of Cuorips?

    Cuorips has 54 total employees.

  • What industry is Cuorips in?

    Cuorips’s primary industry is Biotechnology.

  • Is Cuorips a private or public company?

    Cuorips is a Public company.

  • What is Cuorips’s stock symbol?

    The ticker symbol for Cuorips is 4894.

  • What is the current stock price of Cuorips?

    As of 13-Nov-2026 the stock price of Cuorips is $41.40.

  • What is the current market cap of Cuorips?

    The current market capitalization of Cuorips is $368M.

  • What is Cuorips’s current revenue?

    The trailing twelve month revenue for Cuorips is $833K.

  • What is Cuorips’s annual earnings per share (EPS)?

    Cuorips’s EPS for 12 months was -$0.90.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process